A recent study utilizing data from the Korea National Health Insurance Service–Senior Cohort has established a significant association between antidepressant use and pneumonia hospitalization in older adults aged 60 to 80. The nationwide self-controlled case series analyzed 15,478 individuals who initiated antidepressant therapy between 2008 and 2019. Findings reveal that the risk of pneumonia hospitalization was markedly higher during the 90-day period following antidepressant initiation, with an incidence rate ratio (IRR) of 2.48 overall, peaking at 3.53 in the first 30 days.

This research underscores the clinical implications of antidepressant prescriptions in older populations, particularly given the elevated risk associated with neurologic comorbidities and a high anticholinergic/sedative burden. The study’s results indicate that patients with these characteristics are at a greater risk for pneumonia hospitalization, emphasizing the need for careful assessment of medication regimens in this vulnerable demographic. The graded risk pattern observed suggests that polypharmacy, particularly involving anticholinergic and sedative medications, compounds the likelihood of adverse outcomes.

The findings advocate for a shift in prescribing practices, highlighting the necessity for individualized prescriptions and routine medication reviews to mitigate risks. This study may influence future research directions by prompting investigations into the mechanisms underlying the increased pneumonia risk associated with antidepressants, as well as the development of guidelines for safer prescribing in older adults. As the aging population continues to grow, understanding these associations will be crucial for enhancing healthspan and reducing morbidity in this cohort.

Source: academic.oup.com